Nutra Pharma Corp. (NPHC)

Market Cap	715.97K +9,984.1%
Revenue (ttm)	258.91K -44.1%
Net Income	-5.42M
EPS	-0.00
Shares Out	7.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	450,000
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0050
Beta	60.53
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2026

About Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin/Nyloxin Extra Strength, an over-the-counter (OTC) pain reliever; Pet Pain-Away, a homeopathic, non–narcotic, non–addictive, over–the–counter pain reliever to treat moderate to severe chronic pain in companion animals; Equine Pain-Away, an OTC topical pain reliev...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPHC

Financial Performance

In 2025, Nutra Pharma's revenue was $385,307, a decrease of -1.74% compared to the previous year's $392,150. Losses were -$2.05 million, 59.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 8, 2026

Data Sources Report a data error